PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Breach Candy Hospital, Mumbai, India.\', \'Glenmark Pharmaceuticals Limited, Mumbai, India.\', \'Glenmark Pharmaceuticals Ltd, Waterford, UK.\', \'Glenmark Pharmaceuticals, Inc., Mahwah, NJ, USA.\', \'Glenmark Pharmaceuticals Limited, Mumbai, India. Electronic address: Monika.Tandon@glenmarkpharma.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1201-9712(20)32453-X10.1016/j.ijid.2020.11.142
?:doi
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33212256
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33212256>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33212256>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all